Han Yao
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Ubiquitination of DDX21 by HERC2 induces a dormancy-like phenotype via the NUCKS1-p21/p27 axis to promote radio-resistance in colorectal cancer cells.
Journal: Cell death & disease
Published: November 26, 2025
MS1-96 induces HIP1R-dependent PD-L1 degradation and promotes antitumor immunity in colorectal cancer.
Journal: Acta pharmacologica Sinica
Published: April 21, 2025
Engineering DNA Origami Captors for TGFβ1 Sequestration to Enhance Tumor Immune Modulation and Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 15, 2025
Histone lactylation-boosted AURKB facilitates colorectal cancer progression by inhibiting HNRNPM-mediated PSAT1 mRNA degradation.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 25, 2025
M1-like macrophages regulate T cell infiltration in colorectal cancer through P2X4 receptor.
Journal: iScience
Published: February 15, 2025
TRIM21 promotes colorectal cancer development through regulating DNA replication by TCF3/MCM2/5 axis.
Journal: Cell death discovery
Published: January 25, 2025
Motif-guided identification of KRAS-interacting proteins.
Journal: BMC biology
Published: May 28, 2024
METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells.
Journal: EMBO reports
Published: October 18, 2022
Investigation of the Transporting Behavior of Framework DNA Nano-Devices Across the Artificial Blood-Brain Barrier (BBB).
Journal: Chembiochem : a European journal of chemical biology
Published: August 08, 2022
Self-assembled peptide-paclitaxel nanoparticles for enhancing therapeutic efficacy in colorectal cancer.
Journal: Frontiers in bioengineering and biotechnology
Published: May 07, 2022
FAAH served a key membrane-anchoring and stabilizing role for NLRP3 protein independently of the endocannabinoid system.
Journal: Cell death and differentiation
Published: January 11, 2022
Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer.
Journal: Communications biology
Published: January 11, 2022
Last Updated: 09/26/2026